Primary Amebic MeningoencephalitisSymptoms, Doctors, Treatments, Advances & More
Primary Amebic Meningoencephalitis Overview
Learn About Primary Amebic Meningoencephalitis
University Of Maryland Golisano Children's Hospital
Mark Travassos is a Pediatric Infectious Disease provider practicing medicine in Baltimore, Maryland. Dr. Travassos is rated as an Elite provider by MediFind in the treatment of Primary Amebic Meningoencephalitis. He is also highly rated in 2 other conditions, according to our data. His clinical expertise encompasses Malaria, Primary Amebic Meningoencephalitis, Bacterial Meningitis, and Giardia Infection. Dr. Travassos is board certified in American Board Of Pediatrics - Pediatrics, 2007 and American Board Of Pediatrics - Pediatric Infectious Diseases, 2011. Dr. Travassos is currently accepting new patients.
Montefiore Medical Park At 1575 Blondell
Johanna Daily is an Infectious Disease provider practicing medicine in Bronx, New York. Dr. Daily is rated as an Elite provider by MediFind in the treatment of Primary Amebic Meningoencephalitis. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Primary Amebic Meningoencephalitis, Malaria, Togaviridae Disease, Severe Acute Respiratory Syndrome (SARS), and Leg or Foot Amputation. Dr. Daily is currently accepting new patients.
Michigan State University
Terrie Taylor is a primary care provider, practicing in Internal Medicine in East Lansing, Michigan. Dr. Taylor is rated as an Elite provider by MediFind in the treatment of Primary Amebic Meningoencephalitis. She is also highly rated in 4 other conditions, according to our data. Her clinical expertise encompasses Primary Amebic Meningoencephalitis, Malaria, Sepsis, and Increased Intracranial Pressure.
Summary: The goal of this clinical trial is to evaluate the safety of a single intravenous dose of DON in healthy adults, adults with uncomplicated malaria, and children 12 months-14 years old with clinically defined Cerebral Malaria. The main objectives are: * Evaluate the safety of a single intravenous dose of DON in healthy adults and adults with uncomplicated malaria ( Part 1) * Determine the safety of...
Summary: Toxoplasmosis in HIV-positive individuals is well-studied and has a codified management protocol, which is not the case for other immunodeficiencies, except for recent recommendations in the context of hematopoietic stem cell transplantation. A description of this population is necessary to estimate the number of patients affected and to define their specific management (diagnosis, treatment, prev...

